Probiotics and Diet Modifications: A Holistic Approach to Tackling Helicobacter pylori with the Help of the Gut Microbiota
- PMID: 40794147
- DOI: 10.1007/s12602-025-10706-z
Probiotics and Diet Modifications: A Holistic Approach to Tackling Helicobacter pylori with the Help of the Gut Microbiota
Abstract
Background: Helicobacter pylori (H. pylori) is a common gastrointestinal pathogen that can persist for decades and lead to diseases like gastritis, peptic ulcers, and gastric cancer. Conventional antibiotic treatments have limitations like resistance and side effects, requiring alternative therapies. The gut microbiota may influence H. pylori colonization and eradication success. Strategies like probiotics, prebiotics, diet, and lifestyle changes may modulate the gut microbiota composition and function to inhibit H. pylori growth. Specific probiotic strains produce antimicrobial compounds, modulate immune responses, and alter gut microbiota in ways that can promote H. pylori eradication. Diets high in fiber, polyphenols, omega-3s, and fermented foods appear to inhibit H. pylori by supporting growth of beneficial bacteria. Lifestyle factors like stress, smoking, and alcohol negatively impact the gut microbiota. Personalized therapies based on the gut microbiome could optimize eradication rates.
Conclusion: The gut microbiota represents a promising target for enhancing H. pylori eradication. Further research on microbiota-modulating therapies like probiotics, diet, and lifestyle changes may help develop more effective, personalized treatment approaches.
Keywords: Antibiotic resistance; Diet modifications; Gut microbiota; Helicobacter pylori; Probiotics.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval and Consent to Participate: Not Applicable. Consent for Publi Consent for Publication: Not Applicable. Conflict of Interest: The authors declare no competing interests.
References
-
- Medakina I, Tsapkova L, Polyakova V, Nikolaev S, Yanova T, Dekhnich N et al (2023) Helicobacter pylori Antibiotic Resistance: Molecular Basis and Diagnostic Methods. Int J Mol Sci 24(11). https://doi.org/10.3390/ijms24119433
-
- Addissouky TA, Ali MMA, El Tantawy El Sayed I, Wang Y, El Baz A, Elarabany N et al (2023) Preclinical promise and clinical challenges for innovative therapies targeting liver fibrogenesis. Arch Gastroenterol Res 4(1):14–23. https://doi.org/10.33696/Gastroenterology.4.044
-
- Pop R, Tăbăran F, Ungur AP, Negoescu A, Cătoi C (2022) Helicobacter pylori-Induced gastric infections: from pathogenesis to novel therapeutic approaches using silver nanoparticles. Pharmaceutics 14(7). https://doi.org/10.3390/pharmaceutics14071463
-
- Talebi Bezmin Abadi A, Perez-Perez G (2016) Role of dupA in virulence of Helicobacter pylori. World J Gastroenterol 22(46):10118–10123. https://doi.org/10.3748/wjg.v22.i46.10118 .
-
- Compaore T, Traore K, Compaore N, Traore L, Zida S, Soubeiga S et al (2023) Helicobacter pylori Virulence Genes cagA, babA2, and vacA Detection in Dyspeptic Patients from Burkina Faso. Am J Mol Biol 13:141–155. https://doi.org/10.4236/ajmb.2023.133010 - DOI
LinkOut - more resources
Full Text Sources
